Abstract
Background
Phantom limb pain (PLP) is a detrimental condition that can greatly diminish the quality of life. Purposeful control over the phantom limb activates the affected neural circuitry and leads to dissolution of the pathological relationship linking sensorimotor and pain processing (which gives rise to PLP). An international, double-blind, randomized controlled clinical trial (RCT) on the use of phantom motor execution (PME) as a treatment for PLP is currently undertaken, where PME is compared to an active placebo treatment, namely phantom motor imagery (PMI).
Methods and design
Sixty-seven subjects suffering from PLP in upper or lower limbs are randomly assigned in 2:1 ratio to PME or PMI interventions respectively. Subjects allocated to either treatment receive 15 interventions where they are exposed to the same VR-AR environments using the same device. The only difference between interventions is whether phantom movements are performed (PME) or imagined (PMI).
Results
The primary outcome of the study is to examine whether 15 sessions of PME can induce a greater PLP relief, compared to PMI. The secondary objectives are to examine whether 15 sessions of PME provide a greater improvement in different aspects related to PLP compared to PMI, such as pain duration, pain intensity as measured by other metrics, and the patient’s own impression about the effect of treatment. Long-term retention of treatment benefits will be assessed as change in all the variables (both primary and secondary) between baseline and follow-up timepoints (at 1, 3, and 6 months post-treatment).
Conclusion
This manuscript serves as the formal statistical analysis plan (version 1.0) for the international, double-blind, randomized controlled clinical trial on the use of PME as a treatment for PLP. The statistical analysis plan was completed on 3 August 2021.
Trial registration
ClinicalTrials.govNCT03112928. Registered on April 13, 2017
SAP version: version: 1.0, date: 2021/08/03
Protocol version: This document has been written based on information contained in the study protocol published in Lendaro et al. (BMJ Open 8:e021039, 2018), in July 2018.
SAP revisions: Not applicable
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
; Earley, Eric J. 2 ; Ortiz-Catalan, Max 3 1 Center for Bionics and Pain Research, Mölndal, Sweden; Chalmers University of Technology, Department of Electrical Engineering, Gothenburg, Sweden (GRID:grid.5371.0) (ISNI:0000 0001 0775 6028)
2 Center for Bionics and Pain Research, Mölndal, Sweden (GRID:grid.5371.0); Chalmers University of Technology, Department of Electrical Engineering, Gothenburg, Sweden (GRID:grid.5371.0) (ISNI:0000 0001 0775 6028)
3 Center for Bionics and Pain Research, Mölndal, Sweden (GRID:grid.5371.0); Chalmers University of Technology, Department of Electrical Engineering, Gothenburg, Sweden (GRID:grid.5371.0) (ISNI:0000 0001 0775 6028); Sahlgrenska University Hospital, Operational Area 3, Gothenburg, Sweden (GRID:grid.1649.a) (ISNI:000000009445082X); University of Gothenburg, Department of Orthopaedics, Institute of Clinical Sciences, Sahlgrenska Academy, Gothenburg, Sweden (GRID:grid.8761.8) (ISNI:0000 0000 9919 9582)




